Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis
- PMID: 1465406
- PMCID: PMC50651
- DOI: 10.1073/pnas.89.24.11832
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis
Abstract
Metastasis is a multistep process which requires highly adapted interactions of tumor cells with host target organs. Compared with nonmetastatic cells, metastatic human melanoma cells express 1000-fold higher level of tissue factor (TF), the major cellular initiator of the plasma coagulation protease cascades. To explore whether TF may contribute to metastatic tumor dissemination, we analyzed the effect of specific inhibition of TF function on human melanoma metastasis in severe combined immunodeficient (SCID) mice. Using species-specific antibodies to TF, we demonstrate that initial adherence in insufficient for successful tumor cell implantation in a target organ. Rapid arrest of human tumor cells in the lungs of mice was not diminished by inhibition of TF. However, inhibition of TF receptor function and consequent reduction in local protease generation abolished prolonged adherence of tumor cells, resulting in significantly reduced numbers of tumor cells retained in the vasculature of the lungs. The growth of pulmonary metastases was also significantly inhibited by a blocking anti-TF monoclonal antibody and Fab fragments thereof, whereas a noninhibitory antibody lacked antimetastatic effects. Cell surface expression of functional TF thus contributes to melanoma progression by allowing metastatic cells to provide requisite signals for prolonged adhesive interactions and/or transmigration of tumor cells across the endothelium, resulting in successful metastatic tumor implantation.
Similar articles
-
Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8205-9. doi: 10.1073/pnas.92.18.8205. Proc Natl Acad Sci U S A. 1995. PMID: 7667269 Free PMC article.
-
Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor.Thromb Haemost. 2001 Nov;86(5):1210-4. Thromb Haemost. 2001. PMID: 11816709
-
Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice.Int J Cancer. 2004 Dec 20;112(6):994-1002. doi: 10.1002/ijc.20527. Int J Cancer. 2004. PMID: 15386437
-
Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.Semin Thromb Hemost. 2006 Feb;32(1):54-70. doi: 10.1055/s-2006-933341. Semin Thromb Hemost. 2006. PMID: 16479463 Review.
-
Use of mouse models to study the role of tissue factor in tumor biology.Semin Thromb Hemost. 2008 Mar;34(2):182-6. doi: 10.1055/s-2008-1079258. Semin Thromb Hemost. 2008. PMID: 18645923 Free PMC article. Review.
Cited by
-
The Interface between Inflammation and Coagulation in Cardiovascular Disease.Int J Inflam. 2012;2012:860301. doi: 10.1155/2012/860301. Epub 2012 Feb 19. Int J Inflam. 2012. PMID: 22518344 Free PMC article.
-
Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies.MedComm (2020). 2024 Jul 28;5(8):e671. doi: 10.1002/mco2.671. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39070179 Free PMC article. Review.
-
Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAFv600e mutated melanoma cells in vitro.Cancer Cell Int. 2019 Aug 28;19:223. doi: 10.1186/s12935-019-0938-3. eCollection 2019. Cancer Cell Int. 2019. PMID: 31467489 Free PMC article.
-
Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts.J Transl Med. 2017 Oct 10;15(1):203. doi: 10.1186/s12967-017-1307-4. J Transl Med. 2017. PMID: 29017512 Free PMC article.
-
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival.J Immunother Cancer. 2021 Jan;9(1):e001719. doi: 10.1136/jitc-2020-001719. J Immunother Cancer. 2021. PMID: 33436486 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous